NIH-funded research Career grant

Changing how the brain remembers drug use to help prevent relapse

Official title: Transcriptional reprogramming of drug-associated memories in the nucleus accumbens

Funded at University of Florida · NIH-10982693 · Data updated 2026-11-12

This study is looking at how we can change the memories linked to drug use in the brain to help people stay away from drugs, and it aims to find better ways to support those in recovery from substance use disorders.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$178,416
NIH project number7K01DA054306-04
Project IDNIH-10982693 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals struggling with substance use disorders who have previously undergone treatment but are at risk of relapse.

Less likely to help

Patients who are not currently experiencing substance use issues or those who have not engaged in any form of treatment may not benefit from this research.

What this research studies

This research investigates how memories associated with drug use can be altered in the brain to help individuals maintain abstinence from substances. It focuses on the nucleus accumbens, a brain region involved in regulating these memories and the ability to resist drug-seeking behavior. By understanding the molecular changes that occur during the process of forgetting drug-associated cues, the research aims to develop strategies that could enhance the effectiveness of therapies for substance use disorders. Patients may benefit from insights that could lead to improved treatment options for preventing relapse.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that help individuals with substance use disorders maintain their recovery and avoid relapse.

How similar studies have gone: Previous research has shown promise in altering drug-associated memories, suggesting that this approach could lead to significant advancements in treatment for substance use disorders.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Martinez-Rivera, Freddyson J — University of Florida
  • Study coordinator: Martinez-Rivera, Freddyson J

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.